India, April 22 -- Danaher Corp. (DHR), while reporting weak first-quarter results, but above market estimates, on Tuesday issued outlook for second-quarter revenue and fiscal 2025 earnings. Further, the company maintained annual core revenue growth view.
In pre-market activity on the NYSE, the life sciences and diagnostics company's shares were gaining around 2.8 percent to trade at $190.06.
For the second quarter 2025, the company anticipates that adjusted core revenue will grow low-single digits year-over-year.
For full year 2025, the company expects adjusted net earnings per share in the range of $7.60 to $7.75.
The Wall Street analysts on average expect the company to report earnings of $7.67 per share. Analysts' estimates typicall...